📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate. (2017)

First Author: Migdalska-Richards A

Attributed to: Glucocerebrosidase mutations in Parkinson disease:molecular pathogenesis,and the basis for personalised therapy with small molecule chaperones funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/syn.21967

PubMed Identifier: 28295625

Publication URI: http://europepmc.org/abstract/MED/28295625

Type: Journal Article/Review

Volume: 71

Parent Publication: Synapse (New York, N.Y.)

Issue: 7

ISSN: 0887-4476